Well Lead Medical Co., Ltd. (SHA:603309)
China
· Delayed Price · Currency is CNY 15.98
+0.78 (5.13%)
Mar 10, 2026, 11:30 AM CST
Well Lead Medical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 4,436 | 3,509 | 4,172 | 5,861 | 4,176 | 3,258 | Upgrade
|
| Market Cap Growth | 26.13% | -15.90% | -28.82% | 40.35% | 28.18% | 11.11% | Upgrade
|
| Enterprise Value | 4,646 | 3,675 | 3,991 | 5,495 | 4,254 | 3,279 | Upgrade
|
| Last Close Price | 15.20 | 11.33 | 12.93 | 17.84 | 13.99 | 10.90 | Upgrade
|
| PE Ratio | 18.31 | 15.99 | 21.67 | 35.18 | 39.36 | 21.28 | Upgrade
|
| Forward PE | 14.69 | 80.30 | 80.30 | 80.30 | 80.30 | 80.30 | Upgrade
|
| PS Ratio | 2.71 | 2.33 | 3.01 | 4.30 | 3.73 | 2.88 | Upgrade
|
| PB Ratio | 2.28 | 1.84 | 2.27 | 3.37 | 2.62 | 2.85 | Upgrade
|
| P/TBV Ratio | 3.02 | 2.49 | 3.08 | 4.66 | 3.79 | 4.75 | Upgrade
|
| P/FCF Ratio | 44.82 | - | - | 27.94 | 53.53 | 23.96 | Upgrade
|
| P/OCF Ratio | 12.80 | 11.46 | 18.75 | 14.98 | 22.30 | 14.26 | Upgrade
|
| EV/Sales Ratio | 2.83 | 2.44 | 2.88 | 4.03 | 3.80 | 2.90 | Upgrade
|
| EV/EBITDA Ratio | 12.55 | 11.58 | 13.41 | 21.68 | 21.43 | 12.19 | Upgrade
|
| EV/EBIT Ratio | 15.45 | 14.42 | 17.02 | 27.87 | 28.52 | 14.88 | Upgrade
|
| EV/FCF Ratio | 46.94 | - | - | 26.20 | 54.54 | 24.12 | Upgrade
|
| Debt / Equity Ratio | 0.32 | 0.27 | 0.22 | 0.15 | 0.15 | 0.12 | Upgrade
|
| Debt / EBITDA Ratio | 1.69 | 1.56 | 1.29 | 0.99 | 1.18 | 0.50 | Upgrade
|
| Debt / FCF Ratio | 6.33 | - | - | 1.24 | 3.14 | 0.99 | Upgrade
|
| Net Debt / Equity Ratio | 0.10 | 0.02 | -0.03 | -0.25 | -0.24 | -0.02 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.55 | 0.09 | -0.17 | -1.75 | -1.97 | -0.10 | Upgrade
|
| Net Debt / FCF Ratio | 2.00 | -2.95 | 0.37 | -2.12 | -5.00 | -0.20 | Upgrade
|
| Asset Turnover | 0.58 | 0.55 | 0.56 | 0.60 | 0.62 | 0.77 | Upgrade
|
| Inventory Turnover | 4.70 | 5.43 | 4.98 | 4.74 | 4.29 | 5.38 | Upgrade
|
| Quick Ratio | 1.35 | 1.32 | 1.47 | 1.70 | 1.83 | 1.13 | Upgrade
|
| Current Ratio | 1.78 | 1.67 | 1.85 | 2.08 | 2.29 | 1.82 | Upgrade
|
| Return on Equity (ROE) | 13.48% | 12.22% | 11.44% | 10.67% | 8.38% | 14.67% | Upgrade
|
| Return on Assets (ROA) | 6.66% | 5.85% | 5.87% | 5.46% | 5.15% | 9.35% | Upgrade
|
| Return on Invested Capital (ROIC) | 12.25% | 11.91% | 13.11% | 13.65% | 10.53% | 16.81% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.50% | 11.00% | 10.80% | 10.30% | 8.70% | 17.60% | Upgrade
|
| Earnings Yield | 5.51% | 6.25% | 4.61% | 2.84% | 2.54% | 4.70% | Upgrade
|
| FCF Yield | 2.23% | -0.27% | -3.25% | 3.58% | 1.87% | 4.17% | Upgrade
|
| Dividend Yield | 2.68% | 4.41% | 3.87% | 1.91% | 0.97% | 1.84% | Upgrade
|
| Payout Ratio | 62.63% | 70.93% | 55.50% | 27.31% | 55.20% | 33.05% | Upgrade
|
| Buyback Yield / Dilution | -1.22% | -0.30% | 0.20% | -12.93% | 0.29% | -0.68% | Upgrade
|
| Total Shareholder Return | 1.46% | 4.11% | 4.07% | -11.03% | 1.25% | 1.15% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.